
    
      Subjects will be randomized to one of two study groups:

        -  Group A: Split body treatment. Ultherapy to one axilla, Sham treatment to the other
           axilla.

        -  Group B: Bilateral Ultherapy treatments, with a pre-treatment subcutaneous lidocaine
           injection administered to one axillary side.

      Hyperhidrosis Disease Severity Scale (HDSS), gravimetric test and starch iodine test will be
      obtained at all study visits. Patient satisfaction questionnaires will also be obtained at
      30, 60 and 90 days post-treatment #2.
    
  